Article Sidebar
Published:
Aug 10, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Isosorbide mononitrate inhibits myocardial fibrosis in diabetic rats by up-regulating exosomal MiR-378
Abstract
Purpose: To investigate the effect of isosorbide mononitrate on diabetic cardiomyopathy (DCM), and the potential mechanism of action.
Methods: The effects of isosorbide mononitrate and isosorbide mononitrate + GW4869 on cardiac function and myocardial fibrosis in DCM rats were determined via hemodynamics, hematoxylin-eosin (H&E) staining and Masson staining. Exosomes were extracted from the serum, and the differential expressions of microribonucleic acids (miRNAs) related to myocardial fibrosis were determined by reverse transcription-polymerase chain reaction (qRT-PCR). Western blotting was performed to determine the effects of isosorbide mononitrate and isosorbide mononitrate + GW4869 on IGF1R/STAT3 signaling pathway.
Results: Isosorbide mononitrate exerted a protective effect against DCM--induced cardiac dysfunction and myocardial fibrosis, while such a protective effect was suppressed by the exosome inhibitor GW4869 (p < 0.05). The expression of miR-378 in exosomes significantly rose in isosorbide mononitrate group. The increased expression of miR-378 in vitro inhibited the proliferation of primary myocardial fibroblasts, and reduced the expression of myocardial fibrosis markers (p < 0.05). Luciferase reporter assay data showed that miR-378 negatively regulated the expression of IGF1R by direct binding to IGF1R mRNA 3'-untranslated region (3'UTR). In primary myocardial fibroblasts, miR-378 mimic significantly reduced the protein expressions of IGF1R, p-STAT3/STAT3 and c-Myc (p < 0.05). Isosorbide mononitrate lowered the protein expressions of IGF1R, p-STAT3/STAT3 and c-Myc, but the inhibitory effect was weakened by the exosome inhibitor, GW4869 (p < 0.05).
Conclusion: Isosorbide mononitrate inhibits myocardial fibrosis in diabetic rats by up-regulating exosomal miR-378, and targeting the axis of STAT3/IGF1R. The results of this study may provide a new insight into the treatment of DCM.
